FindTrial
Sign In

Effect of gandharvyadi ghrita nasya in migraine

Randomized controlled clinical trial to evaluate the efficacy of gandharvyadi ghrita nasya in ardhavbhedaka with special reference to migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035700
Enrollment
80
Registered
2021-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

CSMSS ayurved college kanchanwadi aurangabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sign and symptoms of Ardhavbhedaka Age between 16 to 60 years with respect to both gender. Nasya yogya patients

Exclusion criteria

Exclusion criteria: Nasya ayogya Age below 16 and above 60 years Other types of shirodhara such as anantvata, suryavarta, pittaj shirashoola. Patients who were suffering from secondary headache like meningitis, brain tumor, encephalitis, cervical spondylitis.

Design outcomes

Primary

MeasureTime frame
To study gandharvyadi ghrita nasya 8 bindu in each nostril for 7 days in ArdhavbhedakaTimepoint: 7 days with follow up on 1st and 8th day—

Secondary

MeasureTime frame
To compare the effect of gandharvyadi ghrita nasya and go ghrita nasya in Ardhavbhedaka To study nasya karma in detail. To study Ardhavbhedaka in detail according to ayurved Samhita To study Migraine according to modern view.Timepoint: 7 days with follow up on 1st and 8th day—

Countries

India

Contacts

Public ContactDr Rachna Sharma

CSMSS ayurved college kanchanwadi aurangabad

ayurganesh@gmail.com9404109895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026